Treatment with atRA restored this change, induced weight loss, and improved insulin responsiveness, suggesting that suppression of obesity and insulin resistance by atRA is largely mediated by PPARβ/δ. This evidence concerns the gene PPARD and obesity due to melanocortin 4 receptor deficiency.